Resection of the medial wall of the cavernous sinus in functioning pituitary adenomas: Technical note and outcomes in a matched-cohort study

https://doi.org/10.1016/j.clineuro.2020.106306Get rights and content

Highlights

  • Resection of the medial wall of the cavernous sinus is safe and technically feasible using the endonasal endoscopic approach when performed by experienced surgeons.

  • The present Knosp classification of cavernous sinus tumour involvement may not fully reflect microscopic invasion.

  • The value of medial wall resection in improving biochemical remission and oncologic control rates remains to be determined by larger cohorts with matched controls.

Abstract

Background

Parasellar dural invasion can be associated with treatment failure after excision of functioning pituitary adenomas. Because the medial wall of the cavernous sinus is a common site of microscopic disease, we hypothesize that its resection may lead to improvement in biochemical remission and recurrence rates. We aim to describe our technique in the resection of the medial wall of the cavernous sinus using binasal endoscopic transsphenoidal surgery (BETS); and compare tumor control and biochemical remission rates against a matched cohort.

Methods

Patients with functioning pituitary adenomas who underwent resection of the medial cavernous wall in addition to tumor excision via BETS were compared to a cohort matched for tumor type, size, and Knosp grade. Biochemical remission rates, tumor control at follow-up, and complication rates were assessed.

Results

Sixteen patients underwent resection of the medial wall of the cavernous sinus. Of 14 cases with wall specimens deemed adequate for histopathologic analysis, 43 % had microscopic evidence of tumor. Two of three patients with Knosp grade 0 scores had microscopic tumor invasion of the medial wall. The mean blood loss in the cohort was 175 mL (comparable to control, p = 0.895), with no operative complications noted. Gross total excision was achieved in 81 % of cases in the treatment cohort. At a median follow-up of 11 months, no statistical difference was noted in the biochemical remission and oncologic control rates between groups.

Conclusion

Resection of the medial wall of the cavernous sinus is safe and technically feasible using BETS when performed by experienced surgeons. The Knosp classification may not be reliable for microscopic tumor invasion. The effect of this technique on clinical outcomes remains to be determined by larger cohorts with matched controls and long-term follow-up.

Introduction

Functioning pituitary adenomas comprise approximately half of pituitary adenomas and secrete one or more hormones produced by the anterior pituitary, namely prolactin (PRL), growth hormone (GH), adrenocorticotrophic hormone (ACTH), and thyroid-stimulating hormone (TSH) [14,23]. While they are histologically benign, these tumors are associated with a decreased quality of life and increased mortality rate as the patient is exposed to the pathophysiologic effects of hormone hypersecretion [1,3,7,10,11,14,16,23]. Timely biochemical control or cure of functioning pituitary adenomas is an important goal to ultimately improve morbidity and mortality from this disease.

A significant cause of failure after excision of these tumors is the presence of microscopic disease in the surrounding structures [2,8,9,13,20,21]. Microscopic deposits of tumor have been documented in the adjacent sellar dura, and the medial wall of the cavernous sinus [2,6,9,13,15,18,20,22]. It has been hypothesized that microscopic dural invasion decreases the rate of biochemical remission and increases the rate of recurrence after tumor excision [9,13,20,21]. Intuitively, resection of the medial wall of the cavernous sinus may potentially improve outcomes in terms of both biochemical cure and oncologic control.

Resection of the medial wall of the cavernous sinus is a highly technical and potentially morbid procedure due to the intimate relationship of the medial wall to important neurovascular structures including the internal carotid artery (ICA) and the venous plexi. The improvements provided by the fully endoscopic binasal approach to these tumors, however, have allowed for significantly improved lateral visualization and surgical manipulation to make this procedure a possibility [4,5]. Several groups have recently described their technique and presented the results of their early series [2,18,20].

The purpose of this manuscript is to describe our technique for the resection of the medial wall of the cavernous sinus using the BETS and discuss nuances to improve its safety and efficacy. We also compare the biochemical remission and tumor control rates in a cohort utilizing the technique with a cohort matched for tumor type, Knosp grade and size.

Section snippets

Patient population

After approval by the St. Michael’s Hospital Research Ethics Board (REB), the senior author’s (MDC) patient database was reviewed to identify patients with functioning pituitary adenomas who underwent resection of the medial wall of the cavernous sinus in addition to tumor excision using the BETS. Inclusion criteria included: (1) a diagnosis of a functioning pituitary adenoma supported by characteristic clinical manifestations and laboratory evidence of hormone hypersecretion, and confirmed by

Patient and tumor characteristics

A total of sixteen patients met the inclusion criteria. This cohort which underwent medial wall resection had a female predilection (4.1:1) and a mean age of 40.9 years (range: 25–76). The tumor type was GH-secreting pituitary adenoma in 38 %, ACTH-secreting pituitary adenoma in 31 %, and PRL-secreting pituitary adenoma in 31 %. The largest diameter of the tumors ranged from 0.4 to 2.8 cm and had a mean of 1.5 cm. The Knosp grade were as follows: 0 in 19 %, 1 in 13 %, 2 in 38 %, 3 in 13 % and 4

Nuances of technique and avoidance of complication

Our experience with the technique described shows that resection of the medial wall of the cavernous sinus is safe and feasible using the BETS if done by experienced surgeons.

The most common complication reported in previous publications describing the resection of the medial wall for the cavernous sinus for pituitary adenomas was cranial nerve paresis, which was seen in 1 case in Nagata’s series (transient CN III paresis) and in 4 cases in Cohen-Cohen’s cohort (CN VI palsy in most cases).915

Conclusion

Resection of the medial wall of the cavernous sinus is safe and technically feasible using the endonasal endoscopic approach when performed by experienced surgeons. This study also provides data that indicates that the present Knosp classification of cavernous sinus tumour involvement may not fully reflect microscopic invasion, which may be particularly important in establishing biochemical cure of functioning tumors. The value of medial wall resection in improving biochemical remission and

Declaration of Competing Interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the St. Michael’s Hospital Research Ethics Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Funding

No funding was received for this research.

Informed consent

No identifying information on any study subject was included in this article.

CRediT authorship contribution statement

Abdelsimar T. Omar: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing - original draft, Writing - review & editing, Visualization, Supervision, Project administration. David G. Munoz: Methodology, Data curation, Formal analysis, Investigation, Data curation, Writing - review & editing. Jeannette Goguen: Methodology, Formal analysis, Investigation, Data curation, Writing - review & editing. John M. Lee: Methodology, Formal analysis,

References (24)

  • Y. Nagata et al.

    Removal of the medial wall of the cavernous sinus for functional pituitary adenomas: a technical report and pathologic significance

    World Neurosurg.

    (2019)
  • R.N. Clayton et al.

    Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature

    J. Clin. Endocrinol. Metab.

    (2011)
  • S. Cohen-Cohen et al.

    The medial wall of the cavernous sinus. Part 2: selective medial wall resection in 50 pituitary adenoma patients

    J. Neurosurg.

    (2019)
  • M.D. Cusimano

    Quality-of-life assessment in patients with lesions of the cranial base

    Skull Base

    (1999)
  • M.D. Cusimano et al.

    The technique for endoscopic pituitary tumor removal

    Neurosurg. Focus

    (1996)
  • M.D. Cusimano et al.

    Outcomes of surgically treated giant pituitary tumours

    Can. J. Neurol. Sci.

    (2012)
  • G. Daita et al.

    Cavernous sinus invasion by pituitary adenomas--relationship between magnetic resonance imaging findings and histologically verified dural invasion

    Neurol. Med. Chir. (Tokyo)

    (1995)
  • O.M. Dekkers et al.

    Mortality in acromegaly: a metaanalysis

    J. Clin. Endocrinol. Metab.

    (2008)
  • A. Di Ieva et al.

    Aggressive pituitary adenomas—diagnosis and emerging treatments

    Nat. Rev. Endocrinol.

    (2014)
  • R.D. Dickerman et al.

    Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery

    J. Neurosurg.

    (2002)
  • H. Fathalla et al.

    Endoscopic transphenoidal surgery for acromegaly improves quality of life

    Can. J. Neurol. Sci./J. Can. Des. Sci. Neurol.

    (2014)
  • I. Huguet et al.

    Cushing’s disease – quality of life, recurrence and long-term morbidity

    Neuro Endocrinol. Lett.

    (2015)
  • Cited by (0)

    View full text